Skip to main content

Table 4 Total transfusion amounts received by patients

From: The efficacy of recombinant human soluble thrombomodulin for obstetric disseminated intravascular coagulation: a retrospective study

  rhTM group Control group P valuea
  (n = 37) (n = 28)
RBC, units, mean (median)    
 Non-adjusted 5.65 (4.00) 4.83 (2.00) 0.164
 Adjusted 4.90 (4.00) 5.62 (4.00) 0.876
FFP, units, mean (median)    
 Non-adjusted 7.73 (5.00) 5.93 (5.00) 0.360
 Adjusted 7.02 (5.00) 6.65 (5.00) 0.537
PC, units, mean (median)    
 Non-adjusted 3.11 (0.00) 6.21 (0.00) 0.098
 Adjusted 3.02 (0.00) 6.03 (0.00) 0.016
Fibrinogen, g, mean (median)    
 Non-adjusted 0.32 (0.00) 0.17 (0.00) 0.822
 Adjusted 0.49 (0.00) 0.22 (0.00) 0.706
  1. Data are expressed as group mean (median). a P value between the two groups in the Kruskal–Wallis test. RBC red blood cells, FFP fresh frozen plasma, PC platelet concentrate